Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |